A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Harnessing nanoparticles for phytochemical delivery: a comprehensive review of safety and therapeutic potential
Tekijät: Oladipupo, Sharon; Rotimi, Damilare Emmanuel; Ezenabor, Emmanuel Henry; Ojo, Adebola Busola; Akinsola, Oluwatomisin Aderonke; Ojo, Oluwafemi Adeleke
Kustantaja: Taylor & Francis
Julkaisuvuosi: 2025
Lehti:Therapeutic Delivery
ISSN: 2041-5990
eISSN: 2041-6008
DOI: https://doi.org/10.1080/20415990.2025.2570638
Verkko-osoite: https://doi.org/10.1080/20415990.2025.2570638
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/504672707
Nanoparticle encapsulation has emerged as a relevant technology with the potential to revolutionize multiple fields, including medicine, food technology, cosmetics, and environmental monitoring. This review discusses the fundamental aspects of nanoparticle encapsulation, highlighting its benefits, such as enhanced solubility, stability, and bioavailability of phytochemicals. The data for this report were obtained via an extensive review of the peer-reviewed scientific literature. We reviewed various types of nanoparticles used in encapsulation, the efficacy of nanoparticle-encapsulated phytochemicals, and the challenges faced, including formulation complexity and regulatory hurdles. The review also considers current and future applications, providing examples of how advanced technologies such as artificial intelligence and novel manufacturing methods contribute to innovation in this field. As nanoparticle technology progresses, addressing safety and regulatory issues will be critical for its successful integration and commercialization. This review underscores the promising future of nanoparticle technology.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
Dr. Oluwafemi Ojo has been co-funded by the European Union’s Horizon Europe Framework Programme for Research and Innovation 2021–2027 under the Marie Sklodowska-Curie action grant agreement No. 101126611.